Furthermore, in vivo models of MBSHH display exaggerated lipogenesis, with lipidome alterations detectable between in vivo models of non-metastatic and metastatic MBSHH, indicative of concordance between lipid metabolism and medulloblastoma tumour progression and highlighting the YB-1-lipidome interaction as an intriguing area for further study [60,61]. Here, YBX1 is linked to medulloblastoma.